Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa
- PMID: 31691015
- PMCID: PMC6907737
- DOI: 10.1007/s00404-019-05338-y
Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa
Abstract
Purpose: The incidence of placenta accreta spectrum (PAS; pathologic diagnosis of placenta accreta, increta or percreta) continues to rise in the USA. The purpose of this study is to compare the hemorrhagic morbidity associated with PAS with and without a placenta previa.
Methods: This was a retrospective cohort study of 105 deliveries from 1997 to 2017 with histologically confirmed PAS comparing outcomes in women with and without a coexisting placenta previa. We used the Wilcoxon rank sum test to compare continuous data and Chi-square or Fisher's exact test for categorical data. We also performed log-binomial regression to calculate risk ratios adjusted for depth of invasion (aRR) and 95% confidence intervals (CI).
Results: We identified 105 pregnancies with PAS. Antenatal diagnosis of PAS was higher in women with coexisting placenta previa (72.3%) than those without (6.9%, p < 0.001). Women with coexisting placenta previa had greater median estimated blood loss and more units of packed red blood cells transfused (both p ≤ 0.03). Women with placenta previa were more likely to undergo a hysterectomy (RR 2.7; 95% CI 1.8-3.8) and be admitted to the intensive care unit (aRR 3.3; 95% CI 1.1-9.6).
Conclusions: Among women with PAS, those with a coexisting placenta previa experienced greater hemorrhagic morbidity compared to those without. In addition, PAS without placenta previa typically was not diagnosed prior to delivery. This study further supports the recommendation for multi-disciplinary planning and assurance of resources for pregnancies complicated by PAS. In addition, our results highlight the need for mobilization of resources for those pregnancies where PAS is not diagnosed until delivery.
Keywords: Maternal morbidity; Obstetrics hemorrhage; Placenta accreta spectrum; Placenta previa.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Focal-occult placenta accreta: a clandestine source of maternal morbidity.Am J Obstet Gynecol MFM. 2023 Jun;5(6):100924. doi: 10.1016/j.ajogmf.2023.100924. Epub 2023 Mar 18. Am J Obstet Gynecol MFM. 2023. PMID: 36934974
-
[Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].Zhonghua Fu Chan Ke Za Zhi. 2021 Dec 25;56(12):861-867. doi: 10.3760/cma.j.cn112141-20210822-00458. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 34954965 Chinese.
-
The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience.Aust N Z J Obstet Gynaecol. 2019 Aug;59(4):550-554. doi: 10.1111/ajo.12932. Epub 2018 Dec 18. Aust N Z J Obstet Gynaecol. 2019. PMID: 30565213
-
Pathologically diagnosed placenta accreta spectrum without placenta previa: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2023 Aug;5(8):101027. doi: 10.1016/j.ajogmf.2023.101027. Epub 2023 May 19. Am J Obstet Gynecol MFM. 2023. PMID: 37211089 Review.
-
Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.Am J Obstet Gynecol. 2017 Jul;217(1):27-36. doi: 10.1016/j.ajog.2017.02.050. Epub 2017 Mar 6. Am J Obstet Gynecol. 2017. PMID: 28268196 Review.
Cited by
-
Clinical Characteristics, Prenatal Diagnosis and Outcomes of Placenta Accreta Spectrum in Different Placental Locations: A Retrospective Cohort Study.Int J Womens Health. 2024 Jan 26;16:155-162. doi: 10.2147/IJWH.S439654. eCollection 2024. Int J Womens Health. 2024. PMID: 38292300 Free PMC article.
-
Circulating microparticle proteins predict pregnancies complicated by placenta accreta spectrum.Sci Rep. 2023 Jan 5;12(1):21922. doi: 10.1038/s41598-022-24869-0. Sci Rep. 2023. PMID: 36604494 Free PMC article.
-
Accuracy of Magnetic Resonance Imaging in Diagnosing Placenta Accreta: A Systematic Review and Meta-Analysis.Comput Math Methods Med. 2022 Aug 26;2022:2751559. doi: 10.1155/2022/2751559. eCollection 2022. Comput Math Methods Med. 2022. PMID: 36060665 Free PMC article.
-
Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder.JAMA Netw Open. 2022 Aug 1;5(8):e2228002. doi: 10.1001/jamanetworkopen.2022.28002. JAMA Netw Open. 2022. PMID: 35994286 Free PMC article.
-
Placenta accreta spectrum disorders-experience of management in a German tertiary perinatal centre.Arch Gynecol Obstet. 2021 Jun;303(6):1451-1460. doi: 10.1007/s00404-020-05875-x. Epub 2020 Dec 7. Arch Gynecol Obstet. 2021. PMID: 33284419 Free PMC article.
References
-
- O’Brien JM, Barton JR, Donaldson ES. (1996) The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 175(6):1632–1638. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources